<h4>Connective Tissue Disorder</h4>
<table class="table table-bordered">
	<thead>
	<tr>
		<th width="10%">CODE</th>
		<th width="70%">TEST</th>
		<th width="10%">METHOD</th>
		<th width="10%">TAT</th>
	</tr>
	</thead>
	<tbody>
	<tr>
		<td align="left">MGM010</td>
		<td align="left">Achondroplasia (<em>FGFR3</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM011</td>
		<td align="left">Connective tissue disorder gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM012</td>
		<td align="left">Cutis-laxa gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM013</td>
		<td align="left">Ehler Danlos syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM014</td>
		<td align="left">Marfan’s syndrome (<em>FBN1</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM015</td>
		<td align="left">Marfan’s syndrome (<em>FBN1</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM016</td>
		<td align="left">Osteogenesis imperfecta gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM017</td>
		<td align="left">Osteopetrosis gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM018</td>
		<td align="left">Pachydermoperiostosis &amp; primary hypertrophic osteoarthropathy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM019</td>
		<td align="left">Skeletal dysplasia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	</tbody>
</table>